Captopril Export Market Intelligence: India's 109 Suppliers Shipping to 63 Countries — TransData Nexus 2026

Q: Who are the top captopril exporters from India?

The top captopril exporters from India are: 1. LINCOLN PHARMACEUTICALS LTD — $7.9M (63.6% market share); 2. AJANTA PHARMA LIMITED — $1.3M (10.5% market share); 3. GRACURE PHARMACEUTICALS LIMITED — $686.2K (5.5% market share); 4. BIOMATRIX HEALTHCARE PRIVATE LIMITED — $243.8K (2.0% market share); 5. TORRENT PHARMACEUTICALS LTD — $235.9K (1.9% market share). Together they account for 83.5% of India's total captopril export value.

Q: What is the total export value of captopril from India?

The total export value of captopril from India is $12.4M USD, recorded across 517 shipment transactions from 109 active exporters to 63 destination countries. The average shipment value is $24.0K.

Q: Which countries import captopril from India?

India exports captopril to 63 countries worldwide. The top importing countries are: TANZANIA (64.8% share, $8.0M), UNITED STATES (10.6% share, $1.3M), BELGIUM (5.5% share, $686.2K), DOMINICAN REPUBLIC (2.4% share, $295.0K), SOUTH AFRICA (2.3% share, $280.9K). These five markets account for 85.6% of total export value.

Q: What is the HS code for captopril exports from India?

The primary HS code for captopril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of captopril exports from India?

The average unit price for captopril exports from India is $4.62 USD per unit, with prices ranging from $0.01 to $352.21 depending on formulation, packaging, and order volume. The total market is valued at $12.4M across 517 shipments.

Q: Which ports handle captopril exports from India?

The primary ports for captopril exports from India are NHAVA SHEVA SEA (INNSA1) (18.6% of shipments), JNPT/ NHAVA SHEVA SEA (8.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (6.8% of shipments), JNPT (5.4% of shipments), AHEMDABAD ICD (5.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of captopril?

India is one of the world's leading exporters of captopril due to its large base of 109 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports captopril to 63 countries, demonstrating 32% global market coverage.

Q: What certifications do Indian captopril exporters need?

Indian captopril exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import captopril from India?

There are 170 registered buyers importing captopril from India, spread across 63 countries. The repeat buyer rate is 50.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top captopril supplier from India?

LINCOLN PHARMACEUTICALS LTD is the leading captopril exporter from India with a market share of 63.6% and total export value of $7.9M across 20 shipments. The top 5 suppliers together control 83.5% of total export value.

Suresh Sormare

Captopril

India Pharmaceutical Trade Intelligence

$12.4M109 Suppliers63 CountriesHS 30049071

ExportsIndia → TANZANIA64.8%India → UNITED STATES10.6%

ImportsGERMANY → India$368 MALTA → India$244

#1 Buyer: MEDICAL STORES

Captopril Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Captopril to the World

Between 2022 and 2026, India exported $12.4M worth of captopril across 517 verified shipments to 63 countries — covering 32% of world markets in the Cardiovascular segment. The largest destination is TANZANIA (64.8%). LINCOLN PHARMACEUTICALS LTD leads with a 63.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049071

Captopril export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Captopril export data snapshot — $12.4M · 109 exporters · 63 countriesTransData Nexus · Indian Customs Data

Top Captopril Exporters from India

109 active exporters · Ranked by export value

View all 109 →

Top Captopril Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LINCOLN PHARMACEUTICALS LTD	$7.9M	20	2	63.6%
2	AJANTA PHARMA LIMITED

Top Countries Importing Captopril from India

63 destination markets · Ranked by import value

All 63 countries →

Top Countries Importing Captopril from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	TANZANIA	$8.0M	64.8%
2	UNITED STATES	$1.3M	10.6%
3	BELGIUM	$686.2K	5.5%
4	DOMINICAN REPUBLIC	$295.0K	2.4%
5	SOUTH AFRICA	$280.9K	2.3%
6	CONGO DR	$270.2K	2.2%
7	VENEZUELA	$215.8K	1.7%
8	RWANDA	$182.4K	1.5%
9	UGANDA	$158.8K	1.3%
10	ANGOLA	$151.8K	1.2%

TANZANIA is India's largest captopril export destination, absorbing 64.8% of total exports worth $8.0M. The top 5 importing countries — TANZANIA, UNITED STATES, BELGIUM, DOMINICAN REPUBLIC, SOUTH AFRICA — together account for 85.6% of India's total captopril export value. The remaining 58 destination countries collectively receive the other 14.4%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Captopril to India?

5 origin countries · Total import value: $745

India imports captopril from 5 countries with a combined import value of $745. The largest supplier is GERMANY ($368, 16 shipments), followed by MALTA and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Captopril to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$368	16	49.4%
2	MALTA	$244	2	32.7%
3	CANADA	$76	4	10.2%
4	UNITED KINGDOM	$55	4	7.3%
5	GAMBIA	$3	2	0.4%

GERMANY is the largest supplier of captopril to India, accounting for 49.4% of total import value. The top 5 origin countries — GERMANY, MALTA, CANADA, UNITED KINGDOM, GAMBIA — together supply 100.0% of India's captopril imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Captopril

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, captopril is approved for treating hypertension and certain types of heart failure. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for captopril, indicating a competitive generic market. As of March 2026, there are no active FDA import alerts specifically targeting captopril from India, suggesting compliance with U.S. regulatory standards. However, Indian exporters must adhere to stringent FDA requirements, including Good Manufacturing Practices (GMP) and accurate labeling, to maintain market access. The presence of 109 active Indian exporters underscores the importance of regulatory compliance to sustain market share.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, captopril is authorized for hypertension and heart failure management. The European Medicines Agency (EMA) oversees marketing authorizations, ensuring compliance with EU GMP standards. Periodic safety update reports (PSURs) are mandated to monitor the benefit-risk balance of captopril-containing products. For instance, in January 2017, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updates to the product information for captopril/hydrochlorothiazide combinations to reflect new safety data. Manufacturers exporting to these regions must align with EMA and UK Medicines and Healthcare products Regulatory Agency (MHRA) guidelines to ensure continued market presence.

3WHO Essential Medicines & Global Standards

Captopril is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in global health. The WHO Prequalification Programme ensures that medicines meet global standards of quality, safety, and efficacy. Captopril formulations are expected to comply with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards is crucial for Indian exporters to maintain credibility and access in international markets.

4India Regulatory Classification

In India, captopril is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its price to ensure affordability. As of March 2026, the ceiling price for captopril is set at INR 2.50 per 25 mg tablet. For exports, the Directorate General of Foreign Trade (DGFT) requires a No Objection Certificate (NOC) to ensure that domestic supply is not adversely affected. Compliance with these regulations is essential for manufacturers to operate within legal frameworks and maintain export eligibility.

5Patent & Exclusivity Status

Captopril's primary patents have expired, leading to a robust generic market. This expiration allows multiple manufacturers to produce and export captopril, intensifying competition and driving down prices. Indian exporters benefit from this scenario, leveraging cost-effective production to capture significant market shares globally.

6Recent Industry Developments

In June 2025, the NPPA revised the ceiling price for captopril, reducing it by 5% to enhance affordability. In September 2025, the EMA's PRAC recommended updates to the product information for captopril-containing medicines to include new safety warnings regarding potential renal impairment. In December 2025, the FDA approved a new generic version of captopril, increasing competition in the U.S. market. In February 2026, the WHO updated its Model List of Essential Medicines, reaffirming captopril's inclusion due to its efficacy and safety profile. In March 2026, the DGFT streamlined the export NOC process for pharmaceuticals, reducing approval times by 20%, benefiting captopril exporters.

These developments highlight the dynamic regulatory environment affecting captopril's production and export. Indian manufacturers must stay informed and compliant with evolving regulations to maintain and expand their global market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Captopril

Retail & reference prices across 9 markets vs. India FOB export price of $4.62/unit

Global Price Benchmark for Captopril across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, Captopril is available as a generic medication, contributing to its affordability.
United Kingdom	$0.11	GBP	The NHS Drug Tariff lists Captopril as a reimbursable medication, ensuring its availability at controlled prices.
Germany	$0.10	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates the pricing and availability of Captopril in Germany.
Australia	$0.11

Supply Chain Risk Assessment — Captopril

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Captopril, an angiotensin-converting enzyme (ACE) inhibitor, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) often relies on Key Starting Materials (KSMs) sourced from China. This dependency poses a significant risk, as any disruption in the supply of these KSMs can halt API production, leading to shortages of the final pharmaceutical product. The U.S. Pharmacopeia has highlighted that 41% of KSMs used in U.S.-approved APIs are solely sourced from China, underscoring the vulnerability of the supply chain.

Recent geopolitical tensions and trade disputes have further exacerbated this risk. For instance, in February 2026, the U.S. government introduced the BIOSECURE Act, aiming to reduce reliance on foreign pharmaceutical components, particularly from China. Such measures can disrupt established supply chains, affecting the availability of essential drugs like Captopril.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates a high supplier concentration in the export of Captopril from India. The top five exporters account for 83.5% of the total export value, with LINCOLN PHARMACEUTICALS LTD alone contributing 63.6%. This concentration increases the risk of supply disruptions, as any operational issues within these key companies can significantly impact global availability.

Access Complete Captopril Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 517 transactions across 63 markets.

Request Demo View Pricing

Frequently Asked Questions — Captopril Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top captopril exporters from India?

The leading captopril exporters from India are LINCOLN PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED, GRACURE PHARMACEUTICALS LIMITED, and 11 others. LINCOLN PHARMACEUTICALS LTD leads with 63.6% market share ($7.9M). The top 5 suppliers together control 83.5% of total export value.

What is the total export value of captopril from India?

The total export value of captopril from India is $12.4M, recorded across 517 shipments from 109 active exporters to 63 countries. The average shipment value is $24.0K.

Which countries import captopril from India?

India exports captopril to 63 countries. The top importing countries are TANZANIA (64.8%), UNITED STATES (10.6%), BELGIUM (5.5%), DOMINICAN REPUBLIC (2.4%), SOUTH AFRICA (2.3%), which together account for 85.6% of total export value.

What is the HS code for captopril exports from India?

The primary HS code for captopril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Captopril

Captopril

Top Captopril Exporters from India

Top Countries Importing Captopril from India

Who Supplies Captopril to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Captopril

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Captopril

Supply Chain Risk Assessment — Captopril

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Captopril Trade Intelligence

Frequently Asked Questions — Captopril Exports from India

Who are the top captopril exporters from India?

What is the total export value of captopril from India?

Which countries import captopril from India?

What is the HS code for captopril exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of captopril exports from India?

Which ports handle captopril exports from India?

Why is India a leading exporter of captopril?

What certifications do Indian captopril exporters need?

How many buyers import captopril from India?

What is the market share of the top captopril exporter from India?

Analysis Methodology